AtriCure announced that it has completed successful first-in-human procedures at Victoria Heart Hospital in Australia using a dual energy ablation platform that combines Pulsed Field Ablation with ...
Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.
( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced ...
A non-surgical procedure called radiofrequency ablation can be highly effective in reducing or eliminating chronic back and joint pain in patients. The procedure can provide long-term relief by ...
A Dallas physician has performed a multiple cooled radiofrequency ablation of the sacroiliac joint using new equipment, marking the first such procedure to be performed in the state. During the ...
Many people with arthritic knee pain turn to total knee replacements in hopes of alleviating the debilitating condition. Yet, about 15-30% of people who opt for the surgery continue to suffer from ...
Radiofrequency-based ablation for atrial fibrillation appears more effective than previously shown in clinical trials. Using real-world data, a new study found that the procedure eliminated atrial ...
Radiofrequency ablation (RFA) is a procedure aiming to shrink the sizes of nodules and tumors or treat pain. RFA is not a cure-all solution, however. Back pain may not go away after RFA or may come ...
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...
Cardiac Ablation Market by Trends, Dynamic Innovation in Technology Key Players and Forecast to 2030
Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...
CHICAGO--(BUSINESS WIRE)--Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results